Centre for Future Affordable Sustainable Therapy Development

FAST (Centre for Future Affordable & Sustainable Therapy Development) is an independent national centre of expertise and collaboration, devoted to driving innovation in therapy development. Serving as a dynamic network infrastructure, FAST consolidates knowledge, fosters dialogues, and engages an extensive range of experts. The centre identifies key opportunities and challenges, addressing them through comprehensive approaches such as use-cases and pilot studies. FAST’s primary focus lies in accelerating, strengthening, and innovating the entire therapy development chain, spanning from initial laboratory research to widespread patient access. The centre strategically connects stakeholders actively engaged in innovative therapy development, fostering collaboration among researchers, patients, entrepreneurs, and regulatory bodies to drive innovation.

Drug repurposing as a fast route to affordable new therapies

FAST believes there are good opportunities to establish drug repurposing as a fast track to affordable new treatments. A generic brand exemption may encourage companies and/or academic groups to engage in drug repurposing where there is added value for patients, rather than where exclusivity happens to be possible.

Click here for the English version.

Please read the position paper here

FAST's strategy

FAST connects stakeholders who are actively involved in the process of innovative therapy development, such as researchers, patients, and entrepreneurs large and small, from science parks and regulatory agencies to parties that can contribute with additional know-how to innovate the system.

Future therapy development

With an extensive network of partners, FAST works on solutions to complex issues in the process of innovative therapy development and makes expertise and advice available within focus areas. Societal needs and opportunities for the Dutch LSH sector are leading.

Supporting innovators

FAST provides a central place where innovators can receive low-threshold guidance and (regulatory) multidisciplinary support.

Encouraging coherence

FAST provides cohesion and connects various therapy development initiatives and prevents fragmentation.

Addressing opportunities and bottlenecks

The field is surveyed about (future) opportunities and bottlenecks experienced.

Connecting

FAST brings parties together, not just the usual suspects. We look for (inter)national enrichment between scientific, technological and methodological domains.